100mg Imatinib Tablets IP About
Experience unprecedented support in your oncology treatment with Imatib 100 (100mg Imatinib Tablets IP), a hot-selling choice for patients and healthcare providers. Lustrous in its efficacy, Imatib 100 is designed to command response against chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), offering hope and results. Packed securely in blister packs by trusted brand Cipla, each tablet delivers 100 mg of Imatinib, ensuring reliable dosing. Try now under medical supervision. Storage is safe below 30C. Pick yours-prescription only, superior quality guaranteed!
Versatile Application and Trusted Oncology Usage
Imatib 100 is engineered for oral administration, targeting cancer care in patients diagnosed with chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Its application extends across hospitals, specialty oncology clinics, and for use in advanced cancer therapies. Suitable strictly for prescription-only usage, this tablet is favored in oncological protocols and may be recommended as part of combination therapy. Imatib 100 stands as a reliable option in the ongoing fight against specific cancers.
Sample Availability, Export Markets, and Supply Capability
Interested in trialing Imatib 100? Samples are conveniently available for quality evaluation. Cipla ranks as a leading exporter and supplier from India, reaching global export markets including Asia, Africa, the Middle East, and beyond. With robust supply ability ensuring timely delivery, Imatib 100 meets exceedingly competitive rates and list prices suitable for traders and healthcare distributors. Reliable volume, consistent quality, and wide export market access-Imatib 100 is positioned to meet large-scale demands worldwide.
FAQ's of 100mg Imatinib Tablets IP:
Q: How should Imatib 100 Tablets be administered?
A: Imatib 100 Tablets should be taken orally as directed by your prescribing physician, usually once daily with a meal and a glass of water to minimize potential stomach upset.
Q: What conditions is Imatib 100 indicated for?
A: Imatib 100 is indicated for the treatment of certain cancers, specifically chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Use is based on your doctor's assessment and prescription.
Q: When should Imatib 100 not be used?
A: Imatib 100 should not be used without medical supervision or outside of prescribed indications. It is contraindicated in patients allergic to Imatinib or any excipients within the tablet.
Q: Where is Imatib 100 primarily exported and supplied from?
A: Imatib 100 is marketed and exported by Cipla, based in India, and supplied globally to markets across Asia, Africa, the Middle East, and various other international destinations.
Q: What are the storage guidelines for Imatib 100 Tablets?
A: Store Imatib 100 Tablets below 30C, protected from moisture and light, ideally in their original blister packaging to preserve efficacy and shelf life.
Q: How can I request a sample or place a bulk order for Imatib 100?
A: Samples for Imatib 100 are available for evaluation upon request through authorized suppliers or distributors. Bulk orders can be placed directly with traders or exporters associated with Cipla.
Q: What benefits does Imatib 100 provide in cancer treatment?
A: Imatib 100 targets cancer cells with precision, inhibiting abnormal cell growth in CML and GIST cases, thereby improving treatment outcomes when used as part of an oncologist-directed therapy plan.